| RU2613886C2 (en)* | 2010-06-03 | 2017-03-21 | Дженентек, Инк. | Antibodies and immunoconjugates rendered by immuno-positron emission tomography, methods of application |
| CN103068847B (en)* | 2010-08-24 | 2019-05-07 | 罗切格利卡特公司 | Activatable Bispecific Antibodies |
| ES2553874T3 (en)* | 2010-09-29 | 2015-12-14 | Seattle Genetics, Inc. | N-Carboxyalkyl-auristatins and their use |
| HK1206386A1 (en) | 2012-04-04 | 2016-01-08 | Perseus Proteomics Inc. | Conjugate of anti-cdh3 (p-cadherin) antibody and drug |
| BR112016015693A2 (en)* | 2014-01-24 | 2017-10-24 | Genentech Inc | Method To Treat Prostate Cancer And Antibody |
| RS59799B1 (en)* | 2014-04-25 | 2020-02-28 | Pf Medicament | Antibody-drug-conjugate and its use for the treatment of cancer |
| CN107029242A (en) | 2015-11-03 | 2017-08-11 | 财团法人工业技术研究院 | Antibody drug complex and method for producing same |
| JP7327899B2 (en) | 2015-11-25 | 2023-08-16 | レゴケム バイオサイエンシズ， インク． | Antibody-Drug Conjugates Containing Branched Linkers and Related Methods |
| EP3604311A4 (en) | 2017-03-29 | 2021-01-13 | LegoChem Biosciences, Inc. | PYRROLOBENZODIAZEPE INDIMER PRECURSORS AND LIGAND-LINKER CONJUGATE COMPOUND THEREOF |
| MA49289A (en) | 2017-04-03 | 2020-02-12 | Hoffmann La Roche | ANTIBODIES BINDING TO STEAP-1 |
| CN107167541B (en)* | 2017-07-08 | 2019-08-02 | 万舒（北京）医药科技有限公司 | The method for measuring the DTPA-Zn in rat plasma biological sample |
| TWI859138B (en) | 2018-05-09 | 2024-10-21 | 韓商瑞嘉化學生物科學股份有限公司 | Compositions and methods related to anti-cd19 antibody drug conjugates |
| EP3858386A4 (en) | 2018-09-26 | 2022-10-12 | Jiangsu Hengrui Medicine Co., Ltd. | Ligand-drug conjugate of exatecan analogue, preparation method therefor and application thereof |
| KR102503143B1 (en)* | 2019-03-06 | 2023-02-24 | 주식회사 레고켐 바이오사이언스 | Antibody-drug conjugate comprising antibody against human DLK1 and its use |
| CN113544156B (en) | 2019-04-01 | 2022-11-22 | 江苏恒瑞医药股份有限公司 | Anti-Claudin18.2 antibody and its application |
| CN113906053B (en) | 2019-06-26 | 2022-10-25 | 江苏恒瑞医药股份有限公司 | Anti-CEA antibody and its application |
| CA3150149A1 (en)* | 2019-09-05 | 2021-03-11 | Memorial Sloan Kettering Cancer Center | Anti-steap1 antibodies and uses thereof |
| EP4032892A4 (en) | 2019-09-18 | 2023-10-18 | Baili-Bio (Chengdu) Pharmaceutical Co., Ltd. | CAMPTOTHECIN DERIVATIVE AND CONJUGATE THEREOF |
| EP4173638A1 (en) | 2020-06-30 | 2023-05-03 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Anti-cd70 antibody and application thereof |
| CN116133694A (en) | 2020-10-14 | 2023-05-16 | 江苏恒瑞医药股份有限公司 | Anti-HER3 antibody, anti-HER3 antibody-drug conjugate and medical application thereof |
| CN112924665B (en)* | 2021-02-19 | 2023-10-03 | 山东莱博生物科技有限公司 | Antibody horseradish peroxidase marker and preparation and application thereof |
| KR20230015301A (en) | 2021-07-19 | 2023-01-31 | 맙플렉스 인터내셔널 컴퍼니 리미티드 | Antibody-drug conjugates loaded with two-component toxin and uses thereof |
| WO2023036137A1 (en)* | 2021-09-10 | 2023-03-16 | Wuxi Biologics (Shanghai) Co. Ltd. | Process for preparing highly homogenous antibody-drug conjugates for engineered antibodies |
| US20240116945A1 (en) | 2022-09-02 | 2024-04-11 | Merck Sharp & Dohme Llc | Exatecan-derived topoisomerase-1 inhibitors pharmaceutical compositions, and uses thereof |
| JP2025522671A (en) | 2022-12-14 | 2025-07-17 | メルク・シャープ・アンド・ドーム・エルエルシー | Auristatin linker-payload, pharmaceutical compositions and uses thereof |